Outlook Therapeutics
NASDAQ: OTLK
$0.65
+0.02
(+3.75%)
as on
Outlook Therapeutics Stock Performance
as on September 4, 2026 at 6:59 am IST
Day's Low
Day's High
$0.62$0.67
4.62%
Downside
3.08%
Upside
52 Week's Low
52 Week's High
$0.16$2.5475.22%
Downside
290.38%
Upside
Outlook Therapeutics share price movements today
- Previous Close
- $0.63
- Open
- $0.62
- Volume
- 6.3M
- Market Cap
- $153.7M
- Day's Low - High
- $0.62 - $0.67
- 52 Week Low - High
- $0.16 - $2.54
Outlook Therapeutics Historical Returns
- 1 Month Return
- -36.2 %
- 3 Month Return
- -23.41 %
- 1 Year Return
- -28.39 %
- 3 Year Return
- -86.22 %
- 5 Year Return
- -98.82 %
Outlook Therapeutics Stock Fundamentals & Key Indicators
Check Outlook Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$153.7M
EPS (TTM)
-1.22
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.34
Industry PE ratio
-1.4626335877862595
PEG Ratio
0.003964005909226642
EBITDA
-62.3M
Revenue (TTM)
-1.2M
Profit Margin
195.64%
Return On Equity TTM
222.01%
Outlook Therapeutics Stock Valuation
Track how Outlook Therapeutics P/E has moved over time to understand its valuation trends.
Outlook Therapeutics in the last 5 years
Lowest (-6.23x)
September 30, 2021
Industry (-1.46x)
September 30, 2025
Today (-0.59x)
September 30, 2025
Highest (-0.59x)
September 30, 2025
Today’s Price to Earnings Ratio: -0.59x
Outlook Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Outlook Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $153.7M | -98.82% | -0.34 | 195.64% | NA | |
| BUY | $44.6B | 614.61% | NA | 0.00% | NA | |
| BUY | $137.9B | 174.9% | 31.92 | 86.04% | NA | |
| BUY | $61.6B | -61.21% | -7.98 | -12.57% | NA | |
| BUY | $82.3B | 21.91% | 19.9 | 84.86% | 0.44% |
Stock Returns calculator for Outlook Therapeutics Stock including INR - Dollar returns
The Outlook Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Outlook Therapeutics investment value today
Current value as on today
₹80,134
Returns
Returns from Outlook Therapeutics Stock
Dollar Impact
₹5,430 (+5.43%)
Analyst Recommendation on Outlook Therapeutics Stock
Based on 3 analysts
66.67%
Buy
33.33%
Hold
0.00%
Sell
Based on 3 analysts, 66.66666666666666% of analysts recommend a 'BUY' rating for Outlook Therapeutics. Average target price of $4.9
Outlook Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Outlook Therapeutics.
What analysts predicted
86.73%UPSIDE
Target Price
$4.9
Current Price
$0.65
Analyzed by
3 Analysts
Target
$4.90
Outlook Therapeutics target price $4.9, a slight upside of 86.73% compared to current price of $0.65. According to 3 analysts rating.
Indian Investors' Interest in Outlook Therapeutics Stock
Investment in Outlook Therapeutics Shares on INDmoney has dropped by -28.97% in the last 30 days, indicating reduced investment activity.
Time period: to
Search interest for Outlook Therapeutics Stock has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Outlook Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Outlook Therapeutics Annual Profit & Loss
All numbers in Millions USD
Outlook Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Outlook Therapeutics Annual Cash Flow
All numbers in Millions USD
Outlook Therapeutics News & Key Events
Today's Timeline - 27 July
Mon, 01:55 PM
-Shares rose 7% premarket after FDA approval of LYTENAVA for wet AMD, with analysts predicting up to 290% upside.
Mon, 07:43 PM
-Outlook Therapeutics announces FDA approval of LYTENAVA, the first tailored bevacizumab for wet AMD, initiating commercial rollout.
Insights on Outlook Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 527.1% return, outperforming this stock by 556.7%
- NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 34.0% return, outperforming this stock by 120.1%
NEGATIVE IMPACTPrice Dip
In the last 1 month, OTLK stock has moved down by -31.4%
About Outlook Therapeutics
| Organisation | Outlook Therapeutics |
| Headquarters | 111 S. Wood Avenue, Iselin, NJ, United States, 08830 |
| Industry | Biotechnology |
| CEO | Mr. Robert Charles Jahr |
| E-voting on shares | Click here to vote |
Key Management of Outlook Therapeutics
Name | Title |
|---|---|
Mr. Joel Prieve | Senior Vice President of Licensing and M&A |
Dr. Surendra Sharma M.D. | Senior Vice President of Medical Affairs |
Dr. Jennifer M. Kissner Ph.D. | Senior Vice President of Clinical Development & Regulatory Affairs |
Mr. Jedd Comiskey | Senior VP - Head of Europe |
Mr. Robert Charles Jahr | President, CEO & Director |
FAQs
What is Outlook Therapeutics share price today?
Outlook Therapeutics share price today is $0.65 as on at the close of the market. Outlook Therapeutics share today touched a day high of $0.67 and a low of $0.62.
What is the 52 week high and 52 week low for Outlook Therapeutics share?
Outlook Therapeutics share touched a 52 week high of $2.54 on and a 52 week low of $0.16 on . Outlook Therapeutics stock price today i.e. is closed at $0.65,which is 74.38% down from its 52 week high and 303.48% up from its 52 week low.
What is Outlook Therapeutics's market capitalisation today?
Outlook Therapeutics market capitalisation is $0.00T as on .
How to invest in Outlook Therapeutics Stock (OTLK) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Outlook Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Outlook Therapeutics Shares that will get you 2.3077 shares as per Outlook Therapeutics share price of $0.65 per share as on September 4, 2026 at 1:29 am IST.
What is the minimum amount required to buy Outlook Therapeutics Stock (OTLK) from India?
Indian investors can start investing in Outlook Therapeutics (OTLK) shares with as little as ₹94.475 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹944.75 in Outlook Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Outlook Therapeutics share’s latest price of $0.65 as on September 4, 2026 at 1:29 am IST, you will get 15.3846 shares of Outlook Therapeutics. Learn more about
fractional shares .
What are the returns that Outlook Therapeutics has given to Indian investors in the last 5 years?
Outlook Therapeutics stock has given -98.82% share price returns and 30.37% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?